China Biopharmaceuticals Holdings, Inc., a prominent player in the biopharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in the early 2000s, the company has achieved significant milestones, establishing itself as a leader in the development and production of innovative biopharmaceutical products. Specialising in the research, manufacturing, and distribution of therapeutic drugs, China Biopharmaceuticals focuses on areas such as oncology, infectious diseases, and autoimmune disorders. Its unique portfolio includes monoclonal antibodies and recombinant proteins, which are designed to address unmet medical needs. With a strong market position, China Biopharmaceuticals Holdings has garnered recognition for its commitment to quality and innovation, contributing to advancements in healthcare both domestically and internationally. The company continues to expand its influence, striving to improve patient outcomes through cutting-edge biopharmaceutical solutions.
We don't have data for China Biopharmaceuticals Holdings, Inc., but we can show you information about their parent organization instead.
View parent company